Cefiderocol. Summary and conclusions

Rev Esp Quimioter. 2022 Sep;35 Suppl 2(Suppl 2):45-47. doi: 10.37201/req/s02.07.2022. Epub 2022 Oct 4.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Cefiderocol
  • Cephalosporins* / therapeutic use
  • Drug Resistance, Multiple, Bacterial
  • Humans
  • Microbial Sensitivity Tests

Substances

  • Anti-Bacterial Agents
  • Cephalosporins